A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
Inferred to overlap with: Df(3R)BSC475.
The presence of P+PBac{XP5.WH5}BSC850 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(3R)BSC850 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements P{XP}cryd10630 and PBac{WH}Dysf00491 are 3R:15037858 ;15328813 and the cytological breakpoints predicted from these coordinates are 91F11;92A6.